HomeDiscussions$ELV Q2 '26 Earnings Results & Recap
Elevance Health raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, while raising operating cash flow guidance to $6.0 billion.
Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$ELV Q2 '26 Earnings Results & Recap
Elevance Health raised its full-year 2026 diluted EPS guidance to at least $20.10 and adjusted diluted EPS guidance to at least $27.00, while raising operating cash flow guidance to $6.0 billion.